N-(4-[18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors

被引:6
|
作者
Garcia, Gonzalo [1 ]
Abet, Valentina [1 ]
Alajarin, Ramon [1 ]
Alvarez-Builla, Julio [1 ]
Delgado, Mercedes [2 ]
Garcia-Garcia, Luis [2 ]
Bascunana-Almarcha, Pablo [2 ]
Pena-Salcedo, Carmen [3 ]
Kelly, James [3 ]
Pozo, Miguel A. [2 ,3 ]
机构
[1] Univ Alcala, Dept Quim Organ, Madrid 28871, Spain
[2] Inst Pluridisciplinar UCM, CAI Cartog Cerebral, Madrid 28040, Spain
[3] Inst Tecnol PET, Madrid 28040, Spain
关键词
5-HT1A; Positron emission tomography; Fluorine-18; Radioligand; N-(4-[F-18]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides; NUCLEOPHILIC AROMATIC-SUBSTITUTION; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; RADIOACTIVE METABOLITES; TISSUE DISTRIBUTION; ARYL HALIDES; HUMAN PLASMA; BRAIN; WAY-100635; RADIOLIGAND;
D O I
10.1016/j.ejmech.2014.07.096
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
N-(4-[F-18]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides were prepared by labeling their 4-nitropyridin-2-yl precursors through nitro substitution by the F-18 anion. In vitro and in vivo tests showed that the cyclohexanecarboxamide derivative is a reversible, selective and high affinity 5-HT1A receptor antagonist (IC50 = 0.29 nM, k(i) = 0.18 nM) with high brain uptake, slow brain clearance and stability to defluorination when compared with conventional standards. This PET radioligand is a promising candidate for an improved in vivo quantification of 5-HT1A receptors in neuropsychiatric disorders. (C) 2014 Published by Elsevier Masson SAS.
引用
收藏
页码:795 / 806
页数:12
相关论文
共 50 条
  • [11] [3H]4-(Dimethylamino)-N-(4-(4-(2-Methoxyphenyl)Piperazin-1-yl)Butyl)Benzamide: A Selective Radioligand for Dopamine D3 receptors. II. Quantitative Analysis of Dopamine D3 and D2 Receptor Density Ratio in the Caudate-Putamen
    Xu, Jinbin
    Hassanzadeh, Babak
    Chu, Wenhua
    Tu, Zhude
    Jones, Lynne A.
    Luedtke, Robert R.
    Perlmutter, Joel S.
    Mintun, Mark A.
    Mach, Robert H.
    SYNAPSE, 2010, 64 (06) : 449 - 459
  • [12] Assessment of labelled products with different radioanalytical methods: study on 18F-fluorination reaction of 4-[18F]fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-2-pyridinyl-benzamide (p-[18F]MPPF)
    Koivula, Teija
    Laine, Jaana
    Lipponen, Tiina
    Perhola, Outi
    Kamarainen, Eeva-Liisa
    Bergstrom, Kim
    Solin, Olof
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2010, 286 (03) : 841 - 846
  • [13] Synthesis and initial PET imaging of new potential dopaimine D3 receptor radioligands (E)-4,3,2-[11C]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides
    Gao, MZ
    Mock, BH
    Hutchins, GD
    Zheng, QH
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (22) : 6233 - 6243
  • [14] Synthesis of N-(piperidin-1-yl)-5-(4-methoxyphenyl)-1-(2-chlorophenyl)-4-[18F]fluoro-1H-pyrazole-3-carboxamide by nucleophilic [18F] fluorination:: a PET radiotracer for studying CB1 cannabinoid receptors
    Katoch-Rouse, R
    Horti, AG
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (01) : 93 - 98
  • [15] N-(N-benzylpiperidin-4-yl)-2-[F-18]fluorobenzamide: A potential ligand for PET imaging of sigma receptors
    Shiue, CY
    Shiue, GG
    Zhang, SX
    Wilder, S
    Greenberg, JH
    Benard, F
    Wortman, JA
    Alavi, AA
    NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (07): : 671 - 676
  • [16] Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione:: A novel agonist 5-HT1A receptor PET ligand
    Prabhakaran, J
    Parsey, RV
    Majo, VJ
    Hsiung, SC
    Milak, MS
    Tamir, H
    Simpson, NR
    Van Heertum, RL
    Mann, JJ
    Kumar, JSD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (08) : 2101 - 2104
  • [17] Comparison of 2β-Carbomethoxy-3β-(4-[18F]Fluorophenyl)Tropane and N-(3-[18F]Fluoropropyl)-2β-Carbomethoxy-3β-(4-Fluorophenyl)Nortropane, Tracers for Imaging Dopamine Transporter in Rat
    Marjamaki, Paivi
    Haaparanta, Merja
    Forsback, Sarita
    Fagerholm, Veronica
    Eskola, Olli
    Gronroos, Tove
    Koivula, Teija
    Solin, Olof
    MOLECULAR IMAGING AND BIOLOGY, 2010, 12 (03) : 269 - 277
  • [18] [O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey
    Liow, Jeih-San
    Morse, Cheryl L.
    Lu, Shuiyu
    Frankland, Michael
    Tye, George L.
    Zoghbi, Sami S.
    Gladding, Robert L.
    Shaik, Anver B.
    Innis, Robert B.
    Newman, Amy H.
    Pike, Victor W.
    MOLECULES, 2018, 23 (11):
  • [19] Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl-11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates
    J. S. Dileep Kumar
    Jaya Prabhakaran
    Vattoly J. Majo
    Matthew S. Milak
    Shu-Chi Hsiung
    Hadassah Tamir
    Norman R. Simpson
    Ronald L. Van Heertum
    J. John Mann
    Ramin V. Parsey
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1050 - 1060
  • [20] Synthesis and evaluation of [O-methyl-11C]4-[3-[4-(2-methoxyphenyl)-piperazin-1-yl]propoxyl-4-aza-tricyclo[5.2.1.02,6]dec-8-ene-3,5-dione as a 5-HT1A receptor agonist PET ligand
    Majo, Vattoly J.
    Parsey, Ramin V.
    Prabhakaran, Jaya
    Mann, J. John
    Kumar, J. S. Dileep
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2008, 51 (3-4) : 132 - 136